Bayer announced that the FDA has cleared its Contour Next EZ blood glucose monitoring system for use in patients with diabetes. Contour Next EZ includes an easy-to-use meter and test strip sensors with innovative technology for advanced accuracy.
The Contour Next EZ system utilizes a stable, high signal-to-noise ratio that facilitates accurate determination of blood glucose readings, even at low blood glucose levels. This new technology also ensures that the system remains accurate under a wide range of storage conditions, corrects for common errors and is not affected by hematocrit or many common interfering substances in the blood (eg, acetaminophen, vitamin C).
Contour Next EZ glucose monitoring system is expected to be available this summer.
For more information call (800) 288-8371 or visit www.bayerhealthcare.com.